Prelude Therapeutics Inc

XNAS:PRLD 4:00:00 PM EDT

1.65

+0.13 (+8.55%)

4:57:47 PM EDT: $1.60 -0.05 (-3.03%)

Market Cap (Intraday)	93.38M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$13.67 Million
Adjusted EPS	-$0.13

See more estimates

10-Day MA	$1.55
50-Day MA	$1.41
200-Day MA	$1.01

See more pivots

Prelude Therapeutics Inc Stock, XNAS:PRLD

175 Innovation Boulevard, Wilmington, Delaware 19805

United States of America

Phone: +1.302.467.1280

Number of Employees: 131

http://www.preludetx.com

Description

Prelude Therapeutics, Inc. is a clinical-stage oncology company, which engages in the development of novel precision cancer medicines. It also focuses on the design and development of small molecule agents for cancer medicines. The company was founded by Krishna Vaddi in 2016 and is headquartered in Wilmington, DE.